 The study will enroll approximately 400 patients. Before being assigned to a treatment group participants will be screened for previous exposure to the dengue virus. Dengue naïve and previously exposed participants will then be randomly assigned by chance to one of the two treatment groupswhich will remain undisclosed to the patient and study doctor during the study unless there is an urgent medical need: 